Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Sale of 15,355 MPLT shares, $124.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 15,355 | $124.1K |
| Aug 19, 2026 | MapLight Therapeutics, Inc. (MPLT) | Grant/Award | 13,360 | n/a |
| Jul 18, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 7,155 | $258.7K |
| May 12, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 4,321 | $123.2K |
| May 7, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 9,180 | $252.4K |
| Apr 17, 2026 | MapLight Therapeutics, Inc. (MPLT) | Sale | 2,044 | $54.9K |
| Feb 9, 2026 | MapLight Therapeutics, Inc. (MPLT) | Grant/Award | 13,360 | n/a |
| Jan 29, 2026 | MapLight Therapeutics, Inc. (MPLT) | Tax Withholding | 44,616 | $802.2K |
| Oct 28, 2025 | MapLight Therapeutics, Inc. (MPLT) | Grant/Award | 48,275 | n/a |